Omaxe Limited (NSE:OMAXE)

CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	17,273	14,303	16,562	9,090	14,623	12,419
Market Cap Growth	-8.89%	-13.64%	82.19%	-37.84%	17.75%	-55.53%
Enterprise Value	17,882	15,547	21,643	17,331	25,616	21,893
Last Close Price	94.44	78.20	90.55	49.70	79.95	67.90
Forward PE	-	16.77	16.77	16.77	16.77	16.77
PS Ratio	1.17	0.92	1.03	1.18	2.37	2.61
PB Ratio	-8.80	-7.29	3.39	1.00	1.16	0.87
P/TBV Ratio	-	-	3.83	1.07	1.23	0.92
P/FCF Ratio	-	1.46	1.71	2.01	1.91	2.22
P/OCF Ratio	-	1.42	1.68	1.94	1.87	2.19
EV/Sales Ratio	1.21	1.00	1.34	2.24	4.15	4.60
EV/FCF Ratio	-	1.58	2.23	3.84	3.34	3.92
Debt / Equity Ratio	-4.06	-4.06	1.63	1.22	0.90	1.08
Debt / FCF Ratio	-	0.81	0.82	2.45	1.47	2.74
Asset Turnover	-	0.11	0.12	0.06	0.05	0.04
Inventory Turnover	-	0.19	0.17	0.09	0.06	0.06
Quick Ratio	-	0.08	0.05	0.05	0.05	0.06
Current Ratio	-	0.95	1.02	1.07	1.11	1.17
Return on Equity (ROE)	-	-468.38%	-58.03%	-32.36%	-12.05%	-15.28%
Return on Assets (ROA)	-	-2.81%	-1.79%	-1.75%	-0.51%	-0.97%
Return on Capital (ROIC)	-45.82%	-42.75%	-14.85%	-10.12%	-2.19%	-3.33%
Earnings Yield	-41.93%	-47.96%	-24.31%	-38.27%	-10.91%	-18.94%
FCF Yield	-	68.70%	58.56%	49.68%	52.38%	44.97%
Buyback Yield / Dilution	-0.88%	0.01%	-	-	-	-
Total Shareholder Return	-	0.01%	-	-	-	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.